Publication | Closed Access
Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia
18
Citations
0
References
2017
Year
Proteasome inhibition assays suggest that proteasome is the main target for betulinic acid and its derivatives.